Currently submitted to: JMIR Research Protocols
Date Submitted: Mar 19, 2026
Open Peer Review Period: Mar 19, 2026 - May 14, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Family-Supported Mobile Health Coaching for Middle-Aged Men with Chronic Liver Disease and Metabolic Risk Factors: Protocol for a Parallel-Group Superiority Randomized Controlled Trial
ABSTRACT
Background:
Chronic liver disease (CLD) is a major public health burden, particularly among middle-aged men with metabolic risk factors such as obesity and type 2 diabetes. Although sustained lifestyle modification is critical for preventing disease progression, long-term self-management in this population is often suboptimal. Mobile health interventions show promise for supporting self-management; however, most are patient-centered and rarely incorporate structured family engagement despite evidence highlighting the importance of social support.
Objective:
This study aims to develop and formalize a protocol for a family-supported digital health coaching intervention for middle-aged men with CLD and metabolic risk factors and to evaluate its feasibility and acceptability prior to effectiveness testing.
Methods:
This parallel-group randomized controlled trial, approved by the Institutional Review Board of Y University Health System (Approval No. 4-2025-0117) and sponsored by Y University Health System, will be conducted in Seoul, Republic of Korea. Eligible participants are men aged 40–64 years with CLD for ≥6 months and at least one metabolic risk factor; key exclusions include decompensated cirrhosis and active malignancy within 5 years. A total of 82 patient–family dyads (164 participants) will be randomized (1:1) to either a 12-week smartphone-based intervention grounded in the Information–Motivation–Behavioral Skills model or usual care. The primary outcome is change in Nonalcoholic Fatty Liver Disease Self-Management Questionnaire score from baseline to 12 weeks. Secondary outcomes include perceived social support (MSPSS), depressive symptoms (PHQ-9), family experience (FIES:CI), sleep quality (PSQI-K), and clinical indicators derived from electronic medical records, including body mass index, waist circumference, aspartate aminotransferase, alanine aminotransferase, bilirubin, albumin, triglycerides, high-density lipoprotein cholesterol, and glycated hemoglobin as applicable. Data will be analyzed using repeated-measures analysis to evaluate group-by-time effects under an intention-to-treat framework.
Results:
Expert content validation demonstrated excellent validity (Content Validity Index = 1.00). Usability testing indicated high acceptability (System Usability Scale mean 86.88, standard deviation 7.58). The finalized protocol operationalizes information, motivation, and behavioral skills within a structured digital platform incorporating dyadic family involvement. Enrollment began in May 2025 and is expected to be completed by March 2026.
Conclusions:
This protocol describes the development of a family-supported digital intervention for CLD management and provides a framework for evaluating family-centered self-management strategies in middle-aged men with metabolic risk factors. Clinical Trial: Clinical Research Information Service (KCT0010494), registered on March 25, 2025. Secondary identifiers: none. Individual participant data will be available upon reasonable request following publication.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.